How 4D Path and PathPresenter aim to further AI-enabled digital pathology for breast tumor profiling

The digital pathology software company PathPresenter (Montville, New Jersey) and the precision oncology platform firm 4D Path have entered into a partnership that could improve the diagnostic accuracy of breast tumor profiling.

PathPresenter has developed a digital workflow tool for clinicians, pathologists and pharma companies to aggregate medical data.

The platform can be used for medical education, patient care and management. In addition, pharma companies can use it to create models for drug development.

“For these workflow solutions to be effective, you need good AI models running in the background,” said Dr. Rajendra Singh, co-founder of PathPresenter. “And one of the best companies on the planet right now producing AI models is 4D Path.”

That observation ultimately led to the partnership between the two companies. “It was a natural fit to bring in their AI models into a workflow solution to provide a complete p…

Read more
  • May 19, 2022
  • 0

4D Path and University of Leeds extend partnership to validate oncology platform

The precision oncology company 4D Path has committed to partnering with the U.K.-based University of Leeds at least until 2027. The two entities are already collaborators, having worked together on three completed breast cancer clinical trials. In particular, researchers at the University of Leeds have used 4D Path’s Q-plasia OncoReader Breast software to analyze data from more than 1,000 patients over the past three years. 4D Path says its technology can help in various levels in clinical trials starting from patient recruitment for therapy eligibility, which can be challenging for rare mutations, to designing trials for therapy benefit and potentially suggesting drug target screens. The company's technology supports biomarker profiling and stratification from hematoxylin and eosin (H&E) whole slide biopsy and resection images. The platform can help researchers identify the cancer subtype, grade, presence of human epidermal growth factor receptor 2 (HER2) and horm…
Read more
  • March 16, 2021
  • 0